PERCEPTIVE ADVISORS LLC
Holdings History for Spyre Therapeutics, Inc. - Common Stock (SYRE)
- Symbol
- SYRE on Nasdaq
- Investment type
- Equity / Common Stock
- Latest Disclosed Shares Owned
- 2,574,723 shares
- Security Ownership %
- 4.4%
Shares, Excluding Options vs Price
Value, Excluding Options
Perceptive Advisors LLC ownership in Spyre Therapeutics, Inc. Common Stock (SYRE)
14 Feb 2025 - Perceptive Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,574,723 shares of Spyre Therapeutics, Inc. Common Stock (SYRE).
This represents 4.4% ownership of the company.
This is the first filing by PERCEPTIVE ADVISORS LLC disclosing ownership of Spyre Therapeutics, Inc. Common Stock (SYRE).
| Reporting Name | Ownership % | Change | Value $ | Shares owned | Change | Activity % | Price | Form | Report date | Filing time |
|---|---|---|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 4.4% | -56% | $38,672,339 | 2,574,723 | -10,019,488 | -80% | $15.02 | 13G/A | 31 Dec 2024 | 14 Feb 2025, 16:15 |
| Holdings date | Option | Weight | Change | Value $ | Shares | Change | Activity % | Price | All Holders |
|---|---|---|---|---|---|---|---|---|---|
| 31 Dec 2025 | 1.8% | +1.1% | $100,547,811 | 3,069,225 | +1,839,780 | +150% | $32.76 | Q4 2025 | |
| 30 Sep 2025 | 0.6% | -0.15% | $20,605,498 | 1,229,445 | -300,000 | -20% | $16.76 | Q3 2025 | |
| 30 Jun 2025 | 0.86% | -0.44% | $22,895,792 | 1,529,445 | -783,827 | -34% | $14.97 | Q2 2025 | |
| 31 Mar 2025 | 1.3% | -0.15% | $37,324,644 | 2,313,272 | -261,451 | -10% | $16.14 | Q1 2025 | |
| 31 Dec 2024 | 1.7% | -0.19% | $59,939,551 | 2,574,723 | -297,824 | -10% | $23.28 | Q4 2024 | |
| 30 Sep 2024 | 1.8% | -0.1% | $84,481,607 | 2,872,547 | -158,471 | -5.2% | $29.41 | Q3 2024 | |
| 30 Jun 2024 | 1.7% | +0.2% | $71,259,233 | 3,031,018 | +474,339 | +19% | $23.51 | Q2 2024 | |
| 31 Mar 2024 | 1.7% | -0.04% | $96,974,834 | 2,556,679 | -50,000 | -1.9% | $37.93 | Q1 2024 | |
| 31 Dec 2023 | 1.3% | +1.2% | $56,095,732 | 2,606,679 | +2,525,563 | +3114% | $21.52 | Q4 2023 | |
| 30 Sep 2023 | 0.03% | +0.03% | $993,671 | 81,116 | +81,116 | NEW | $12.25 | Q3 2023 |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.